INO
INOVIO PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.24
+2.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 29.33x
- Price / sales
- —
- Price / cash flow
- -1.59x
Enterprise value
- Enterprise value
- $99.5M
- EV / sales
- —
- EV / EBITDA
- -1.53x
- EV / EBIT
- -1.26x
- Market cap
- $128.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026